EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) – Analysts’ Revisions Show Sentiment Is Improving
EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) traded at $6.54 at close of the session on Tuesday, February 18 and made an upward move of 0.62% on its previous day’s price. EyePoint Pharmaceuticals Inc has a market cap of $446.36 million and is expected to release its quarterly